We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
(+9.1%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$35.4M |
| 2 |
P
Everpure Inc
P
|
+$21M |
| 3 |
NVIDIA
NVDA
|
+$20.7M |
| 4 |
American Homes 4 Rent
AMH
|
+$19.3M |
| 5 |
DAY
Dayforce
DAY
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$46.7M |
| 2 |
Apple
AAPL
|
+$41.8M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$32.3M |
| 4 |
Gilead Sciences
GILD
|
+$27.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.42% |
| 2 | Financials | 13.09% |
| 3 | Healthcare | 11.94% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Apogee Therapeutics
APGE
$10.2B
| $3.7M | ﹤0.01% |
55,696
+28,468
| +105% | +$1.24M |
|
1577
Oscar Health
OSCR
$8.64B
| $3.7M | ﹤0.01% |
248,624
+6,807
| +3% | +$93.2K |
|
1578
Mirion Technologies
MIR
$3.76B
| $3.69M | ﹤0.01% |
324,229
+411
| +0.1% | +$4.12K |
|
|
ACLX
1579
DELISTED
Arcellx
ACLX
| $3.69M | ﹤0.01% |
53,002
+1,567
| +3% | +$99.4K |
|
1580
Allegiant Air
ALGT
$2.44B
| $3.68M | ﹤0.01% |
48,966
-2,800
| -5% | -$212K |
|
1581
Itaú Unibanco
ITUB
$86.9B
| $3.68M | ﹤0.01% |
601,368
-107,783
| -15% | -$649K |
|
1582
Seadrill
SDRL
$2.95B
| $3.68M | ﹤0.01% |
73,122
-4,143
| -5% | -$188K |
|
1583
DHT Holdings
DHT
$2.98B
| $3.67M | ﹤0.01% |
318,931
+96,399
| +43% | +$1.06M |
|
1584
Leslie's
LESL
$10.7M
| $3.67M | ﹤0.01% |
28,197
+308
| +1% | +$44.1K |
|
1585
International Seaways
INSW
$4.54B
| $3.66M | ﹤0.01% |
68,739
-232
| -0.3% | -$12K |
|
1586
Flywire
FLYW
$2.15B
| $3.64M | ﹤0.01% |
146,543
+2,847
| +2% | +$66.5K |
|
1587
Payoneer
PAYO
$2.41B
| $3.64M | ﹤0.01% |
748,038
+1,078
| +0.1% | +$5.25K |
|
|
STEL
1588
DELISTED
Stellar Bancorp
STEL
| $3.63M | ﹤0.01% |
149,201
+330
| +0.2% | +$8.21K |
|
|
AAT
1589
American Assets Trust
AAT
$1.38B
| $3.63M | ﹤0.01% |
165,691
+465
| +0.3% | +$10.3K |
|
1590
CVR Energy
CVI
$3.29B
| $3.63M | ﹤0.01% |
101,689
+505
| +0.5% | +$16.8K |
|
1591
RingCentral
RNG
$5.4B
| $3.62M | ﹤0.01% |
104,293
-11,336
| -10% | -$382K |
|
1592
Perdoceo Education
PRDO
$2.01B
| $3.62M | ﹤0.01% |
206,133
-2,808
| -1% | -$49.6K |
|
1593
Novartis
NVS
$297B
| $3.61M | ﹤0.01% |
37,311
+2,730
| +8% | +$280K |
|
1594
Beam Therapeutics
BEAM
$2.81B
| $3.6M | ﹤0.01% |
109,004
+4,792
| +5% | +$149K |
|
1595
CNA Financial
CNA
$13.8B
| $3.59M | ﹤0.01% |
79,019
-7,233
| -8% | -$319K |
|
1596
Yum China
YUMC
$16.4B
| $3.55M | ﹤0.01% |
89,250
+751
| +0.8% | +$29.6K |
|
1597
Ichor Holdings
ICHR
$2.47B
| $3.53M | ﹤0.01% |
91,528
+357
| +0.4% | +$13.8K |
|
1598
Denali Therapeutics
DNLI
$3.95B
| $3.53M | ﹤0.01% |
171,959
+5,196
| +3% | +$97.7K |
|
1599
Provident Financial Services
PFS
$3.16B
| $3.53M | ﹤0.01% |
242,027
+596
| +0.2% | +$9.47K |
|
1600
Eastern Bankshares
EBC
$5.21B
| $3.52M | ﹤0.01% |
255,172
+6,101
| +2% | +$82.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2024 Portfolio in Review
As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
- RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
- RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
- RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
- RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
- RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
- RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.
Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.